More than 80 pharmaceutical companies have called on governments to develop new ways of paying them to develop antibiotics. With drug-resistant microbes predicted to kill 10 million people a year by 2050 and cost $100 trillion in lost economic output, Redx Pharm chief executive said “there is a doomsday clock ticking, with the effectiveness of antibiotics diminishing at an alarming rate, new ways must be found to support innovation and drug discovery in this critical area”.

“EX-TREME VIRTUAL” ACADEMIC SUPER WEEK 2020

ACADEMIC SUPERWEEK 2020      NOVEMBER    9 - 15...

COVID-19 cited in significant increase in healthcare-associated infections in 2020

According to ScienceDaily, a CDC analysis of...

17-year-old makes color changing sutures that detect infection

Recently the PBS News Hour featured an episode...

La resistencia a los antibióticos en Tanzania es un problema ambiental

Investigadores de la Universidad Estatal de...

How India’s hospitals, rivers and chickens are driving global antibiotic resistance

A 59-year-old man from India, who was living in...

Gene-editing produces tenfold increase in superbug slaying antibiotics

ScienceDaily recently featured a study conducted...

Nuestro reloj biológico juega un papel crucial en la curación de la cirugía.

Según un estudio compartido por ScienceDaily,...

For vampire bats, social distancing while sick comes naturally

ScienceDaily recently featured a study conducted...

By changing their shape, some bacteria can grow more resilient to antibiotics

ScienceDaily recently reported on new research...

¿Qué es la osteomielitis?

El Dr. Pablo S. Corona...

Distribuidor exclusivo.

0